Cargando…

Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry

Historically, donor infection with hepatitis-C virus (HCV) has been a barrier to kidney transplantation. However, in recent years, it has been reported that HCV positive kidney donors transplanted into HCV negative recipients offer acceptable mid-term results. However, acceptance of HCV donors, espe...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Antonio, Moreso, Francesc, Solà-Porta, Eulàlia, Beneyto, Isabel, Esforzado, Núria, Gonzalez-Roncero, Francisco, Sancho, Asunción, Melilli, Edoardo, Ruiz, Juan Carlos, Galeano, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002558/
https://www.ncbi.nlm.nih.gov/pubmed/36902560
http://dx.doi.org/10.3390/jcm12051773
_version_ 1784904417551581184
author Franco, Antonio
Moreso, Francesc
Solà-Porta, Eulàlia
Beneyto, Isabel
Esforzado, Núria
Gonzalez-Roncero, Francisco
Sancho, Asunción
Melilli, Edoardo
Ruiz, Juan Carlos
Galeano, Cristina
author_facet Franco, Antonio
Moreso, Francesc
Solà-Porta, Eulàlia
Beneyto, Isabel
Esforzado, Núria
Gonzalez-Roncero, Francisco
Sancho, Asunción
Melilli, Edoardo
Ruiz, Juan Carlos
Galeano, Cristina
author_sort Franco, Antonio
collection PubMed
description Historically, donor infection with hepatitis-C virus (HCV) has been a barrier to kidney transplantation. However, in recent years, it has been reported that HCV positive kidney donors transplanted into HCV negative recipients offer acceptable mid-term results. However, acceptance of HCV donors, especially viremic, has not broadened in the clinical practice. This is an observational, multicenter, retrospective study including kidney transplants from HCV positive donors into negative recipients reported to the Spanish group from 2013 to 2021. Recipients from viremic donors received peri-transplant treatment with direct antiviral agents (DAA) for 8–12 weeks. We included 75 recipients from 44 HCV non-viremic donors and 41 from 25 HCV viremic donors. Primary non function, delayed graft function, acute rejection rate, renal function at the end of follow up, and patient and graft survival were not different between groups. Viral replication was not detected in recipients from non-viremic donors. Recipient treatment with DAA started pre-transplant avoids (n = 21) or attenuates (n = 5) viral replication but leads to non-different outcomes to post-transplant treatment with DAA (n = 15). HCV seroconversion was more frequent in recipients from viremic donors (73% vs. 16%, p < 0.001). One recipient of a viremic donor died due to hepatocellular carcinoma at 38 months. Donor HCV viremia seems not to be a risk factor for kidney transplant recipients receiving peri-transplant DAA, but continuous surveillance should be advised.
format Online
Article
Text
id pubmed-10002558
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100025582023-03-11 Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry Franco, Antonio Moreso, Francesc Solà-Porta, Eulàlia Beneyto, Isabel Esforzado, Núria Gonzalez-Roncero, Francisco Sancho, Asunción Melilli, Edoardo Ruiz, Juan Carlos Galeano, Cristina J Clin Med Article Historically, donor infection with hepatitis-C virus (HCV) has been a barrier to kidney transplantation. However, in recent years, it has been reported that HCV positive kidney donors transplanted into HCV negative recipients offer acceptable mid-term results. However, acceptance of HCV donors, especially viremic, has not broadened in the clinical practice. This is an observational, multicenter, retrospective study including kidney transplants from HCV positive donors into negative recipients reported to the Spanish group from 2013 to 2021. Recipients from viremic donors received peri-transplant treatment with direct antiviral agents (DAA) for 8–12 weeks. We included 75 recipients from 44 HCV non-viremic donors and 41 from 25 HCV viremic donors. Primary non function, delayed graft function, acute rejection rate, renal function at the end of follow up, and patient and graft survival were not different between groups. Viral replication was not detected in recipients from non-viremic donors. Recipient treatment with DAA started pre-transplant avoids (n = 21) or attenuates (n = 5) viral replication but leads to non-different outcomes to post-transplant treatment with DAA (n = 15). HCV seroconversion was more frequent in recipients from viremic donors (73% vs. 16%, p < 0.001). One recipient of a viremic donor died due to hepatocellular carcinoma at 38 months. Donor HCV viremia seems not to be a risk factor for kidney transplant recipients receiving peri-transplant DAA, but continuous surveillance should be advised. MDPI 2023-02-23 /pmc/articles/PMC10002558/ /pubmed/36902560 http://dx.doi.org/10.3390/jcm12051773 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Franco, Antonio
Moreso, Francesc
Solà-Porta, Eulàlia
Beneyto, Isabel
Esforzado, Núria
Gonzalez-Roncero, Francisco
Sancho, Asunción
Melilli, Edoardo
Ruiz, Juan Carlos
Galeano, Cristina
Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry
title Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry
title_full Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry
title_fullStr Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry
title_full_unstemmed Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry
title_short Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry
title_sort outcome of kidney transplants from viremic and non-viremic hepatitis c virus positive donors into negative recipients: results of the spanish registry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002558/
https://www.ncbi.nlm.nih.gov/pubmed/36902560
http://dx.doi.org/10.3390/jcm12051773
work_keys_str_mv AT francoantonio outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry
AT moresofrancesc outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry
AT solaportaeulalia outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry
AT beneytoisabel outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry
AT esforzadonuria outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry
AT gonzalezroncerofrancisco outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry
AT sanchoasuncion outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry
AT melilliedoardo outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry
AT ruizjuancarlos outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry
AT galeanocristina outcomeofkidneytransplantsfromviremicandnonviremichepatitiscviruspositivedonorsintonegativerecipientsresultsofthespanishregistry